Consumer Discretionary • Specialty Chemicals
$74.38 ▲ +1.71
(+2.35%)
MKT CAP: $3.41B • VOL: 545.5K
52W L $47 52W H $78
ASH // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-09-30 | FY 2024
FILED 2024-09-30 | FY 2023
FILED 2023-09-30 |
|---|---|---|---|
| Revenue (Total Sales) | $1.82B | $2.11B | $2.19B |
| YoY Revenue Growth % | -13.7% | -3.6% | — |
| Gross Profit | $549.0M | $618.0M | — |
| Gross Margin % | 30.1% | 29.2% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$775.0M | -$26.0M | $172.0M |
| Operating Margin % | -42.5% | -1.2% | 7.9% |
| Net Income (GAAP) | $0 | $0 | $0 |
| EBITDA (Normalized) | -$696.6M | $83.6M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | — | — | — |
| Capital Expenditures (CapEx) | $98.0M | $137.0M | — |
| Free Cash Flow (FCF) | — | — | — |
| FCF Margin % | — | — | — |
| Return on Invested Capital (ROIC %) | -20.7% | -0.6% | — |
| Cash & Short-Term Equivalents | $304.0M | $219.0M | — |
| Total Debt (Short + Long Term) | $1.39B | $1.31B | — |
| Total Stockholders' Equity | $1.88B | $2.59B | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR ASH.